Cardioprotective mechanisms of SGLT2 inhibitors: What do cardiologists need to know?
Video navigation menu
- Clinical observations with SGLT2 inhibitor treatment 0:44
- Potential hemodynamic effects of SGLT2 inhibitors 2:09
- Potential metabolic effects of SGLT2 inhibitors 4:15
- Early and long-term effects of SGLT2 inhibitors explained 7:42
This lecture by prof. Nikolaus Marx was part of an accredited symposium "Expanding opportunities for SGLT2i in clinical cardiology" held during ESC 2019 in Paris, France.
Prof. Nikolaus Marx, Professor of Medicine / Cardiology, Head of Department of Internal Medicine I, Cardiology, Angiology, and Intensive Care Medicine, University Hospital Aachen, Germany
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from Boehringer Ingelheim/Lilly.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: